academic article

• Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes..  Clinical cancer research : an official journal of the American Association for Cancer Research.  23:3794-3801. 2017
• PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS..  Journal of medical genetics.  53:800-811. 2016
• Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk..  Genetic epidemiology.  :-. 2015
• Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  :-. 2015
• Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study..  Gynecologic oncology.  136:542-548. 2015
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer. 2015
• Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer..  Nature communications.  6:-. 2015
• Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. 2015